Recombinant CA9 anticorps

N° du produit ABIN6654742

L’anticorps anti-CA9 Monoclonal Lapin est utilisé pour la détection de CA9 dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour Recombinant CA9 anticorps (ABIN6654742)

Antigène: CA9 (Carbonic Anhydrase IX (CA9))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp CA9 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: CA9-2993R

Détail du produit anti-CA9 anticorps

Fonction: Recombinant Carbonic Anhydrase 9 Antibody (azide and preservative free)

Purification: Protein A affinity chromatography

Immunogène: Recombinant human protein was used as the immunogen for this recombinant Carbonic Anhydrase 9 antibody.

Isotype: IgG, kappa

Information d'application

Indications d'application: The optimal dilution of the recombinant Carbonic Anhydrase 9 antibody for each application should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the recombinant Carbonic Anhydrase 9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur CA9

Antigène: CA9 (Carbonic Anhydrase IX (CA9))

Autre désignation: Carbonic Anhydrase 9

Sujet: Recognizes a glycoprotein of ~200 kDa, identified as carbonic anhydrase IX (CAIX/gp200). Its epitope resides in the carbohydrate domain of gp200. It shows no significant cross-reactivity with other carbohydrate determinants, such as the Lewis blood group antigens, epithelial membrane antigen, HMFG, and AB blood group antigens. In normal kidney, gp200 is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Reportedly, gp200 is expressed by 93 % of primary and 84 % of metastatic renal cell carcinomas. This MAb may be useful in the investigations of carcinomas of proximal nephrogenic differentiation especially those showing tubular differentiation.

UniProt: Q16790